301087 可孚医疗
2026/03 - 三个月
人民幣(K¥)
与去年同期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
营业总收入1,012,36837.22%3,387,4992,982,9312,853,6952,976,958
减:营业总成本885,03836.93%3,038,8062,630,6582,594,3862,646,291
    其中:营业成本454,00628.65%1,586,6081,436,0841,618,6611,800,683
               财务费用1,576-198.12%(2,987)(22,828)(19,062)(33,291)
               资产减值损失(16,364)-33.40%(31,813)(33,803)(52,180)(46,304)
公允价值变动收益5,132-29.61%49,8429,400(1,563)4,402
投资收益(2,734)-126.47%15,84512,34247,71556,750
    其中:对联营企业和合营企业的投资收益(2,791)-1,107.11%779(3,498)(130)(21)
营业利润128,66617.32%429,044373,304294,728368,407
利润总额129,03217.92%425,843371,999285,708334,388
减:所得税费用21,62021.10%55,52759,65632,83732,369
净利润107,41217.30%370,316312,344252,871302,020
减:非控股权益370150.50%(1,292)593(1,409)336
股东净利润107,04217.08%371,609311,751254,280301,683

市场价值指针
每股收益 (元) *0.52015.56%1.8301.5301.2401.450
每股派息 (元) *----1.8001.8001.2001.200
每股净资产 (元) *22.652-3.22%23.29822.94023.41424.080
审计意见 #--标准的无保留意见标准的无保留意见标准的无保留意见标准的无保留意见
回页顶
备注: *未调整数据
#只提供简体内容